45 million in a Pre-Series A funding round led by Anara Impact Capital to expand production of its molecular diagnostic tests and grow its presence across Africa and other underserved markets.
Originally published by AllAfrica.
45 million in a Pre-Series A funding round led by Anara Impact Capital to expand production of its molecular diagnostic tests and grow its presence across Africa and other underserved markets.
Originally published by AllAfrica.